Single Gene Inheritance
Autosomal Dominant and Recessive
disorders
Huntigton’s disease, Marfan syndrome, Cystic
fibrosis, Phenylketonuria, Sickle cell disease.
 Most human genetic defects can be categorized
as resulting from either chromosomal, single-
gene Mendelian, single-gene non-Mendelian, or
multifactorial causes.
 Disorders associated with single-gene Mendelian
inheritance are typically categorized as
autosomal dominant, autosomal recessive, or
sex-linked.
Modes of Inheritance
 In autosomal dominant inheritance, only one copy of a
disease allele is necessary for an individual to be susceptible
to expressing the phenotype.
 With each pregnancy, there is a one in two (50%) chance the
offspring will inherit the disease allele.
 Unless a new mutation has occurred, all affected individuals
will have at least one parent who is affected by the disease.
 Dominantly inherited genetic diseases tend to occur in
every generation of a family.
 Dominant mutations can also happen in an individual for
the first time, with no family history of the condition
(spontaneous mutation).
Autosomal Dominant Inheritance
 Autosomal dominant inheritance is often called vertical
inheritance because of the transmission from parent to
offspring.
 Across a population, the proportion of affected males
should be equal to the proportion of affected females.
 Examples of diseases with autosomal dominant
inheritance include Myotonic muscular dystrophy and
Huntington's disease.
Autosomal Dominant Inheritance
 In autosomal recessive inheritance, two copies of a
disease allele are required for an individual to be
susceptible to expressing the phenotype.
 Typically, the parents of an affected individual are
not affected but are gene carriers of a mutated
gene.
 With each pregnancy of carrier parents there is a
one in four (25%) chance the offspring will inherit
two copies of the disease allele and will therefore
have the phenotype.
Autosomal Recessive Inheritance
 There is a one in two (50%) chance the offspring will
inherit one copy of the disease allele and will be a carrier.
 There is a one in four (25%) chance the offspring will
inherit no copies of the disease allele and will not express
the phenotype or be a carrier - this individual would not
be at risk for passing the disorder on to his/her offspring.
 As with autosomal dominant inheritance, the proportion
of affected males should be equal to the proportion of
affected females in a given population.
 Examples of diseases with autosomal recessive
inheritance include sickle cell anemia and cystic fibrosis.
Autosomal Recessive Inheritance
 Huntington disease is a progressive brain disorder-death of brain
cells - that causes uncontrolled movements, emotional problems, and
loss of thinking ability (cognition).
 Adult-onset Huntington disease, the most common form of this
disorder, usually appears in a person's thirties or forties.
 Early signs and symptoms can include irritability, depression, small
involuntary movements, poor coordination, and trouble learning new
information or making decisions.
 Many people with Huntington disease develop involuntary jerking or
twitching movements known as chorea (dyskinesia).
 As the disease progresses, these movements become more
pronounced.
 Affected individuals may have trouble walking, speaking, and
swallowing.
Huntington Disease
 People with this disorder also experience changes in
personality and a decline in thinking and reasoning
abilities.
 Individuals with the adult-onset form of Huntington
disease usually live about 15 to 20 years after signs and
symptoms begin.
 A less common form of Huntington disease known as the
juvenile form begins in childhood or adolescence.
 It also involves movement problems and mental and
emotional changes.
 Additional signs of the juvenile form include slow
movements, clumsiness, frequent falling, rigidity, slurred
speech, and drooling.
 School performance declines as thinking and reasoning
abilities become impaired.
 Seizures occur in 30 percent to 50 percent of children
with this condition.
 Juvenile Huntington disease tends to progress more
quickly than the adult-onset form
 Affected individuals usually live 10 to 15 years after signs
and symptoms appear.
 Mutations in the huntingtin gene (HTT) that is
located on the short arm of chromosome 4, cause
Huntington disease.
 The HTT gene provides instructions for making a
protein called huntingtin.
 Although the function of this protein is unknown, it
appears to play an important role in nerve cells
(neurons) in the brain.
 HTT is expressed in all cells.
Causes
 The highest concentrations are found in the brain
and testes, with moderate amounts in the liver, heart,
and lungs.
 It interacts with proteins which are involved in
transcription, cell signaling, and intracellular
transporting.
 The huntingtin (HTT) mutation that causes
Huntington disease involves a DNA segment known
as a CAG trinucleotide repeat.
 This segment is made up of a series of three DNA
building blocks (cytosine, adenine, and guanine) that
appear multiple times in a row.
 Normally, the CAG segment is repeated 10 to 35
times within the gene.
 In people with Huntington disease, the CAG
segment is repeated 36 to more than 120 times.
 People with 36 to 39 CAG repeats may or may not
develop the signs and symptoms of Huntington
disease, while people with 40 or more repeats
almost always develop the disorder.
 An increase in the size of the CAG segment
leads to the production of an abnormally long
version of the huntingtin protein.
 The elongated protein is cut into smaller, toxic
fragments that bind together and accumulate
in neurons, disrupting the normal functions of
these cells.
 The dysfunction and eventual death of neurons
in certain areas of the brain underlie the signs
and symptoms of Huntington disease.
 This condition is inherited in an autosomal dominant
pattern, which means one copy of the altered gene
in each cell is sufficient to cause the disorder.
 An affected person usually inherits the altered gene
from one affected parent.
 In rare cases, an individual with Huntington disease
does not have a parent with the disorder.
 As the altered HTT gene is passed from one
generation to the next, the size of the CAG
trinucleotide repeat often increases in size.
 A larger number of repeats is usually associated
with an earlier onset of signs and symptoms.
 This phenomenon is called anticipation.
Inheritance Pattern.
 Medical diagnosis of the onset of HD can be made
following the appearance of physical symptoms
specific to the disease.
 Genetic testing can be used to confirm a physical
diagnosis if there is no family history of HD.
 Even before the onset of symptoms, genetic testing
can confirm if an individual or embryo carries an
expanded copy of the trinucleotide repeat in the
HTT gene that causes the disease.
HD Diagnosis
 There is no cure for HD, but there are treatments
available to reduce the severity of some of its
symptoms.
 Treatments can relieve some symptoms and in
some improve quality of life.
 Full-time care is required in the later stages of the
disease.
Treatment
 Current research directions include:
◦ determining the exact mechanism of the
disease.
◦ improving animal models to aid with research.
◦ testing of medications to treat symptoms or
slow the progression of the disease.
◦ studying procedures such as stem cell therapy
with the goal of repairing damage caused by
the disease.
 Marfan syndrome (MFS) is a genetic disorder of the
connective tissue.
 It is named after Antoine Marfan, a French pediatrician who
first described the condition in 1896.
 MFS is an autosomal dominant disorder
 About 1 in 5,000 to 10,000 individuals have Marfan
syndrome.
 It occurs equally in males and females, rates are similar
between races and in different regions of the world.
 About 75% of the time, the condition is inherited from a
parent, while 25% of the time it is a new mutation.
Marfan Syndrome (MFS)
 More than 30 different signs and symptoms are
variably associated with Marfan syndrome.
The most prominent of these affect the skeletal,
cardiovascular, and ocular systems, but all fibrous
connective tissue throughout the body can be
affected.
Signs and Symptoms
 People with Marfan tend to be tall and thin, with long arms,
legs, fingers and toes.
 They also typically have flexible joints and scoliosis.
 The most serious complications involve the heart and aorta,
with an increased risk of mitral valve prolapse and aortic
aneurysm.
 Other commonly affected areas include the lungs, eyes, bones
and the covering of the spinal cord.
 It involves a mutation to the gene that makes fibrillin, which
results in abnormal connective tissue.
 A diagnosis is based on family history and a combination of
major and minor indicators of the disorder.
 Diagnostic criteria of MFS - Ghent nosology - were agreed upon
internationally in 1996 and then revised in 2010.
 There is no known cure for Marfan syndrome.
 Many people have a normal life expectancy with
proper treatment.
 Management often includes the use of beta
blockers.
 Surgery may be required to repair the aorta or
replace a heart valve.
 It is recommended that energetic exercise be
avoided.
 Regular checkups are recommended to monitor
the health of the heart valves and the aorta.
Management.
 Cystic fibrosis is an inherited disease characterized by the buildup
of thick, sticky mucus that can damage many of the body's organs.
 The disease occurs in 1 in 2,500 to 3,500 white newborns. Cystic
fibrosis is less common in other ethnic groups, affecting about 1 in
17,000 African Americans and 1 in 31,000 Asian Americans.
 The most common signs and symptoms include progressive
damage to the respiratory system and chronic digestive system
problems.
 The features of the disorder and their severity varies among
affected individuals.
 In people with cystic fibrosis, the body produces mucus that is
abnormally thick and sticky.
Cystic Fibrosis
 This abnormal mucus can clog the airways,
leading to severe problems with breathing and
bacterial infections in the lungs.
 These infections cause chronic coughing,
wheezing, and inflammation.
 Over time, mucus buildup and infections result
in permanent lung damage, including the
formation of scar tissue (fibrosis) and cysts in
the lungs.
 In people with cystic fibrosis, mucus often
damages the pancreas, impairing its ability to
produce insulin and digestive enzymes.
 Problems with digestion can lead to diarrhea,
malnutrition, poor growth, and weight loss.
 In adolescence or adulthood, a shortage of
insulin can cause a form of diabetes known as
cystic fibrosis-related diabetes mellitus
(CFRDM).
 Cystic fibrosis used to be considered a fatal
disease of childhood.
 Adults with cystic fibrosis experience health
problems affecting the respiratory, digestive, and
reproductive systems.
 Most men with cystic fibrosis have congenital
bilateral absence of the vas deferens (CBAVD), a
condition in which the tubes that carry sperm are
blocked by mucus and do not develop properly,
causing infertility unless the fertility treatment.
 Women with cystic fibrosis may experience
complications in pregnancy.
Health problems associated
with cystic fibrosis
 Mutations in the transmembrane conductance regulator
(CFTR gene) on chromosome 7 cause cystic fibrosis.
 The CFTR gene provides instructions for making a
channel that transports negatively charged particles
called chloride ions into and out of cells.
 Chloride is a component of sodium chloride, a common
salt found in sweat.
 Chloride also has important functions in cells; for
example, the flow of chloride ions helps control the
movement of water in tissues, which is necessary for the
production of thin, freely flowing mucus.
Causes
 Mutations in the CFTR gene disrupt the function
of the chloride channels, preventing them from
regulating the flow of chloride ions and water
across cell membranes.
 As a result, cells that line the passageways of the
lungs, pancreas, and other organs produce
mucus that is unusually thick and sticky.
 This mucus clogs the airways and various ducts,
causing the characteristic signs and symptoms
of cystic fibrosis.
 Other genetic and environmental factors likely
influence the severity of the condition.
 For example, mutations in genes other than
CFTR might help explain why some people with
cystic fibrosis are more severely affected than
others.
 Most of these genetic changes have not been
identified, however.
 This condition is inherited in an autosomal recessive
pattern, which means both copies of the gene in each cell
have mutations.
 The parents of an individual with an autosomal recessive
condition each carry one copy of the mutated gene, but
they typically do not show signs and symptoms of the
condition.
 If two carriers have a child, there is a:
◦ 25 percent, or 1 in 4, chance the child will have CF
◦ 50 percent, or 1 in 2, chance the child will be a carrier but will not
have CF
◦ 25 percent, or 1 in 4, chance the child will not be a carrier and will
not have CF
Inheritance Pattern
 Cystic fibrosis may be diagnosed by many different methods, including
newborn screening, sweat testing, and genetic testing.
 There is currently no cure for CF.
 Treatment can manage the symptoms of the disease, however, and
improve quality of life.
 It is crucial for people with CF to get rid of mucus from their lungs to
allow clear breathing and minimize lung infections.
 Inhaled medication is effective at reaching the airways and commonly
used.
 Antibiotics are an important part of regular care.
 Gene therapy has been explored as a potential cure for CF. Results from
clinical trials have shown limited success as of 2016, and using gene
therapy as routine therapy is not suggested.
Diagnosis and Management
 Phenylketonuria (PKU) is an inherited disorder with
decreased metabolism of the amino acid phenylalanine,
resulting in increased levels of this amino acid in the
blood.
 This condition is inherited in an autosomal recessive
pattern, which means both copies of the gene in each cell
have mutations.
 The parents of an individual with an autosomal recessive
condition each carry one copy of the mutated gene, but
they typically do not show signs and symptoms of the
condition.
Phenilketonuria.
 Phenylalanine is a building block of proteins that
is obtained through the diet.
 When Phe cannot be metabolized by the body, a
typical diet that would be healthy for people
without PKU causes abnormally high levels of Phe
to accumulate in the blood, which is toxic to the
brain.
 If PKU is not treated, phenylalanine can build up
to harmful levels in the body, causing intellectual
disability and other serious health problems.
 The signs and symptoms of PKU vary from mild to
severe.
 The most severe form of this disorder is known as
classic PKU.
 Infants with classic PKU appear normal until they
are a few months old.
 Without treatment, these children develop
permanent intellectual disability.
 Seizures, delayed development, behavioral
problems, and psychiatric disorders are also
common.
 Untreated individuals may have a musty or mouse-
like odor as a side effect of excess phenylalanine in
the body.
 Children with classic PKU tend to have lighter skin
and hair than unaffected family members and are
also likely to have skin disorders such as eczema.
 Less severe forms of this condition, sometimes
called variant PKU and non-PKU
hyperphenylalaninemia, have a smaller risk of
brain damage.
 People with very mild cases may not require
treatment with a low-phenylalanine diet.
 Babies born to mothers who have PKU and
uncontrolled phenylalanine levels (women who no
longer follow a low-phenylalanine diet) have a
significant risk of intellectual disability because
they are exposed to very high levels of
phenylalanine before birth.
 These infants may also have a low birth weight and
grow more slowly than other children.
Abnormally small head (microcephaly)
 Mutations in the PAH gene cause phenylketonuria.
 The PAH gene provides instructions for making an enzyme
called phenylalanine hydroxylase.
 This enzyme converts the amino acid phenylalanine to other
important amino acid tyrosine.
 If gene mutations reduce the activity of phenylalanine
hydroxylase, phenylalanine from the diet is not processed
effectively.
 Phenylalanine accumulates and is converted into
phenylpyruvate (also known as phenylketone), which can be
detected in the urine.
 As a result, this amino acid can build up to toxic levels in the
blood and other tissues.
 Because nerve cells in the brain are particularly sensitive to
phenylalanine levels, excessive amounts of this substance can
cause brain damage.
Causes
 Classic PKU, the most severe form of the disorder, occurs
when phenylalanine hydroxylase activity is severely
reduced or absent.
 People with untreated classic PKU have levels of
phenylalanine high enough to cause severe brain damage
and other serious health problems.
 Mutations in the PAH gene that allow the enzyme to retain
some activity result in milder versions of this condition,
such as variant PKU or non-PKU hyperphenylalaninemia.
 Changes in other genes may influence the severity of PKU,
but little is known about these additional genetic factors.
 PKU is commonly included in the newborn screening
panel of many countries, with varied detection
techniques.
 Most babies in developed countries are screened for
PKU soon after birth.
 PKU is not curable.
 However, if PKU is diagnosed early enough, an affected
newborn can grow up with normal brain development by
managing and controlling phenylalanine ("Phe") levels
through diet, or a combination of diet and medication.
Diagnosis and Management
 People who follow the prescribed dietary
treatment from birth may have no symptoms.
 Their PKU would be detectable only by a blood
test.
 People must adhere to a special diet low in Phe
for optimal brain development.
 Since Phe is necessary for the synthesis of
many proteins, it is required for appropriate
growth, but levels must be strictly controlled.
 The diet requires restricting or eliminating
foods high in Phe, such as soybeans, egg
whites, shrimp, chicken breast, spirulina,
watercress, fish, nuts, crayfish, lobster, tuna,
turkey, legumes, and lowfat cottage cheese.
 Starchy foods, such as potatoes and corn are
generally acceptable in controlled amounts, but
the quantity of Phe consumed from these
foods must be monitored.
 Sickle cell disease is a group of disorders that affects
hemoglobin, the molecule in red blood cells that delivers
oxygen to cells throughout the body.
 This condition is inherited in an autosomal recessive pattern.
 People with this disorder have atypical hemoglobin
molecules called hemoglobin S, which can distort red blood
cells into a sickle, or crescent, shape.
 Signs and symptoms of sickle cell disease usually begin in
early childhood.
 Characteristic features of this disorder include a low number
of red blood cells (anemia), repeated infections, and periodic
episodes of pain.
Sickle Cell Disease
 The severity of symptoms varies from person to
person.
 The signs and symptoms of sickle cell disease are
caused by the sickling of red blood cells.
 When red blood cells sickle, they break down
prematurely, which can lead to anemia
 Anemia can cause shortness of breath, fatigue, and
delayed growth and development in children.
 The rapid breakdown of red blood cells may also
cause yellowing of the eyes and skin, which are
signs of jaundice.
 Painful episodes can occur when sickled red blood cells,
which are stiff and inflexible, get stuck in small blood
vessels.
 These episodes deprive tissues and organs of oxygen-
rich blood and can lead to organ damage, especially in
the lungs, kidneys, spleen, and brain.
 A particularly serious complication of sickle cell disease
is high blood pressure in the blood vessels that supply
the lungs (pulmonary hypertension).
 Pulmonary hypertension occurs in about one-third of
adults with sickle cell disease and can lead to heart
failure.
 Sickle cell disease affects millions of people worldwide.
 It is most common among people whose ancestors
come from Africa; Mediterranean countries such as
Greece, Turkey, and Italy; the Arabian Peninsula; India;
and Spanish-speaking regions in South America, Central
America, and parts of the Caribbean.
 The disease is estimated to occur in 1 in 500 African
Americans and 1 in 1,000 to 1,400 Hispanic Americans.
Frequency
 Mutations in the HBB gene (chromosome 11)
cause sickle cell disease.
 Hemoglobin consists of four protein subunits,
typically, two subunits called alpha-globin and two
subunits called beta-globin.
 The HBB gene provides instructions for making
beta-globin.
 Various versions of beta-globin result from
different mutations in the HBB gene.
Causes
 One particular HBB gene mutation produces an
abnormal version of beta-globin known as
hemoglobin S (HbS).
 Other mutations in the HBB gene lead to
additional abnormal versions of beta-globin such
as hemoglobin C (HbC) and hemoglobin E (HbE).
 HBB gene mutations can also result in an
unusually low level of beta-globin.
 This abnormality is called beta thalassemia.
 If mutations that produce hemoglobin S and beta
thalassemia occur together, individuals have
hemoglobin S-beta thalassemia (HbSBetaThal)
disease.
 Abnormal versions of beta-globin can distort red
blood cells into a sickle shape.
 The sickle-shaped red blood cells die prematurely,
which can lead to anemia.
 Sometimes the inflexible, sickle-shaped cells get
stuck in small blood vessels and can cause serious
medical complications.
 In HbS, the complete blood count reveals low
hemoglobin levels with a high reticulocyte count.
 Abnormal hemoglobin forms can be detected on
hemoglobin electrophoresis.
 Sickle cell hemoglobin (HgbS) and hemoglobin C
with sickling (HgbSC)—the two most common
forms—can be identified from there.
Diagnosis
 Albinism is a genetic disorder characterized in
humans by the complete or partial absence of
pigment in the skin, hair and eyes.
 Albinism is associated with a number of vision
defects.
 Lack of skin pigmentation makes for more
susceptibility to sunburn and skin cancers.
 Albinism results from inheritance of recessive
gene alleles and is known to affect all vertebrates,
including humans.
Albinism
 It is due to absence or defect of tyrosinase, a
copper-containing enzyme involved in the
production of melanin.
 Albinism is considered to be a hereditary
condition characterised by the absence of
melanin in particular, in the eyes, skin, hair or
feathers.
 While an organism with complete absence of
melanin is called an albino, an organism with
only a diminished amount of melanin is
described as albinoid.
 There are two principal types of albinism:
oculocutaneous, affecting the eyes, skin and hair,
and ocular affecting the eyes only.
 Because individuals with albinism have skin that
entirely lacks the dark pigment melanin, which
helps protect the skin from the sun's ultraviolet
radiation, their skin can burn more easily from
overexposure.
 Those with albinism are generally as healthy as the
rest of the population, with growth and
development occurring as normal, and albinism by
itself does not cause mortality
 Although the lack of pigment blocking ultraviolet
radiation increases the risk of melanomas (skin
cancers) and other problems.
 Oculocutaneous albinism is generally the result of
the biological inheritance of genetically recessive
alleles (genes) passed from both parents of an
individual for example OCA1 and OCA2.
 Some rare forms are inherited from only one parent.
 There are other genetic mutations which are proven
to be associated with albinism.
 All alterations, however, lead to changes in melanin
production in the body
 Some of these are associated with increased risk of
skin cancer.
Causes
 The chance of offspring with albinism resulting from
the pairing of an organism with albinism and one
without albinism is low.
 Albinism usually occurs with equal frequency in both
sexes.
 An exception to this is ocular albinism, which it is
passed on to offspring through X-linked inheritance.
 Thus, ocular albinism occurs more frequently in males
as they have a single X and Y chromosome, unlike
females, whose genetics are characterized by two X
chromosomes.
 People with albinism will have the following symptoms:
◦ an absence of color in the hair, skin, or eyes
◦ lighter than normal coloring of the hair, skin, or eyes
◦ patches of skin that have an absence of color
 Albinism occurs with vision problems, which may
include:
◦ strabismus (crossed eyes)
◦ photophobia (sensitivity to light)
◦ nystagmus (involuntary rapid eye movements)
◦ impaired vision or blindness
◦ astigmatism
Symptoms
 Since there is no cure for albinism, it is
managed through lifestyle adjustments.
 People with albinism need to take care not to
get sunburnt and should have regular healthy
skin checks by a dermatologist.
 Most forms of albinism don’t affect life span.
Management
Thank You!

15. Single gene inheritance.pptbmcmlxklx

  • 1.
    Single Gene Inheritance AutosomalDominant and Recessive disorders Huntigton’s disease, Marfan syndrome, Cystic fibrosis, Phenylketonuria, Sickle cell disease.
  • 2.
     Most humangenetic defects can be categorized as resulting from either chromosomal, single- gene Mendelian, single-gene non-Mendelian, or multifactorial causes.  Disorders associated with single-gene Mendelian inheritance are typically categorized as autosomal dominant, autosomal recessive, or sex-linked. Modes of Inheritance
  • 3.
     In autosomaldominant inheritance, only one copy of a disease allele is necessary for an individual to be susceptible to expressing the phenotype.  With each pregnancy, there is a one in two (50%) chance the offspring will inherit the disease allele.  Unless a new mutation has occurred, all affected individuals will have at least one parent who is affected by the disease.  Dominantly inherited genetic diseases tend to occur in every generation of a family.  Dominant mutations can also happen in an individual for the first time, with no family history of the condition (spontaneous mutation). Autosomal Dominant Inheritance
  • 4.
     Autosomal dominantinheritance is often called vertical inheritance because of the transmission from parent to offspring.  Across a population, the proportion of affected males should be equal to the proportion of affected females.  Examples of diseases with autosomal dominant inheritance include Myotonic muscular dystrophy and Huntington's disease. Autosomal Dominant Inheritance
  • 5.
     In autosomalrecessive inheritance, two copies of a disease allele are required for an individual to be susceptible to expressing the phenotype.  Typically, the parents of an affected individual are not affected but are gene carriers of a mutated gene.  With each pregnancy of carrier parents there is a one in four (25%) chance the offspring will inherit two copies of the disease allele and will therefore have the phenotype. Autosomal Recessive Inheritance
  • 6.
     There isa one in two (50%) chance the offspring will inherit one copy of the disease allele and will be a carrier.  There is a one in four (25%) chance the offspring will inherit no copies of the disease allele and will not express the phenotype or be a carrier - this individual would not be at risk for passing the disorder on to his/her offspring.  As with autosomal dominant inheritance, the proportion of affected males should be equal to the proportion of affected females in a given population.  Examples of diseases with autosomal recessive inheritance include sickle cell anemia and cystic fibrosis. Autosomal Recessive Inheritance
  • 7.
     Huntington diseaseis a progressive brain disorder-death of brain cells - that causes uncontrolled movements, emotional problems, and loss of thinking ability (cognition).  Adult-onset Huntington disease, the most common form of this disorder, usually appears in a person's thirties or forties.  Early signs and symptoms can include irritability, depression, small involuntary movements, poor coordination, and trouble learning new information or making decisions.  Many people with Huntington disease develop involuntary jerking or twitching movements known as chorea (dyskinesia).  As the disease progresses, these movements become more pronounced.  Affected individuals may have trouble walking, speaking, and swallowing. Huntington Disease
  • 8.
     People withthis disorder also experience changes in personality and a decline in thinking and reasoning abilities.  Individuals with the adult-onset form of Huntington disease usually live about 15 to 20 years after signs and symptoms begin.  A less common form of Huntington disease known as the juvenile form begins in childhood or adolescence.  It also involves movement problems and mental and emotional changes.
  • 9.
     Additional signsof the juvenile form include slow movements, clumsiness, frequent falling, rigidity, slurred speech, and drooling.  School performance declines as thinking and reasoning abilities become impaired.  Seizures occur in 30 percent to 50 percent of children with this condition.  Juvenile Huntington disease tends to progress more quickly than the adult-onset form  Affected individuals usually live 10 to 15 years after signs and symptoms appear.
  • 10.
     Mutations inthe huntingtin gene (HTT) that is located on the short arm of chromosome 4, cause Huntington disease.  The HTT gene provides instructions for making a protein called huntingtin.  Although the function of this protein is unknown, it appears to play an important role in nerve cells (neurons) in the brain.  HTT is expressed in all cells. Causes
  • 11.
     The highestconcentrations are found in the brain and testes, with moderate amounts in the liver, heart, and lungs.  It interacts with proteins which are involved in transcription, cell signaling, and intracellular transporting.  The huntingtin (HTT) mutation that causes Huntington disease involves a DNA segment known as a CAG trinucleotide repeat.  This segment is made up of a series of three DNA building blocks (cytosine, adenine, and guanine) that appear multiple times in a row.
  • 12.
     Normally, theCAG segment is repeated 10 to 35 times within the gene.  In people with Huntington disease, the CAG segment is repeated 36 to more than 120 times.  People with 36 to 39 CAG repeats may or may not develop the signs and symptoms of Huntington disease, while people with 40 or more repeats almost always develop the disorder.
  • 13.
     An increasein the size of the CAG segment leads to the production of an abnormally long version of the huntingtin protein.  The elongated protein is cut into smaller, toxic fragments that bind together and accumulate in neurons, disrupting the normal functions of these cells.  The dysfunction and eventual death of neurons in certain areas of the brain underlie the signs and symptoms of Huntington disease.
  • 14.
     This conditionis inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.  An affected person usually inherits the altered gene from one affected parent.  In rare cases, an individual with Huntington disease does not have a parent with the disorder.  As the altered HTT gene is passed from one generation to the next, the size of the CAG trinucleotide repeat often increases in size.  A larger number of repeats is usually associated with an earlier onset of signs and symptoms.  This phenomenon is called anticipation. Inheritance Pattern.
  • 15.
     Medical diagnosisof the onset of HD can be made following the appearance of physical symptoms specific to the disease.  Genetic testing can be used to confirm a physical diagnosis if there is no family history of HD.  Even before the onset of symptoms, genetic testing can confirm if an individual or embryo carries an expanded copy of the trinucleotide repeat in the HTT gene that causes the disease. HD Diagnosis
  • 16.
     There isno cure for HD, but there are treatments available to reduce the severity of some of its symptoms.  Treatments can relieve some symptoms and in some improve quality of life.  Full-time care is required in the later stages of the disease. Treatment
  • 17.
     Current researchdirections include: ◦ determining the exact mechanism of the disease. ◦ improving animal models to aid with research. ◦ testing of medications to treat symptoms or slow the progression of the disease. ◦ studying procedures such as stem cell therapy with the goal of repairing damage caused by the disease.
  • 18.
     Marfan syndrome(MFS) is a genetic disorder of the connective tissue.  It is named after Antoine Marfan, a French pediatrician who first described the condition in 1896.  MFS is an autosomal dominant disorder  About 1 in 5,000 to 10,000 individuals have Marfan syndrome.  It occurs equally in males and females, rates are similar between races and in different regions of the world.  About 75% of the time, the condition is inherited from a parent, while 25% of the time it is a new mutation. Marfan Syndrome (MFS)
  • 19.
     More than30 different signs and symptoms are variably associated with Marfan syndrome. The most prominent of these affect the skeletal, cardiovascular, and ocular systems, but all fibrous connective tissue throughout the body can be affected. Signs and Symptoms
  • 20.
     People withMarfan tend to be tall and thin, with long arms, legs, fingers and toes.  They also typically have flexible joints and scoliosis.  The most serious complications involve the heart and aorta, with an increased risk of mitral valve prolapse and aortic aneurysm.  Other commonly affected areas include the lungs, eyes, bones and the covering of the spinal cord.  It involves a mutation to the gene that makes fibrillin, which results in abnormal connective tissue.  A diagnosis is based on family history and a combination of major and minor indicators of the disorder.  Diagnostic criteria of MFS - Ghent nosology - were agreed upon internationally in 1996 and then revised in 2010.
  • 22.
     There isno known cure for Marfan syndrome.  Many people have a normal life expectancy with proper treatment.  Management often includes the use of beta blockers.  Surgery may be required to repair the aorta or replace a heart valve.  It is recommended that energetic exercise be avoided.  Regular checkups are recommended to monitor the health of the heart valves and the aorta. Management.
  • 23.
     Cystic fibrosisis an inherited disease characterized by the buildup of thick, sticky mucus that can damage many of the body's organs.  The disease occurs in 1 in 2,500 to 3,500 white newborns. Cystic fibrosis is less common in other ethnic groups, affecting about 1 in 17,000 African Americans and 1 in 31,000 Asian Americans.  The most common signs and symptoms include progressive damage to the respiratory system and chronic digestive system problems.  The features of the disorder and their severity varies among affected individuals.  In people with cystic fibrosis, the body produces mucus that is abnormally thick and sticky. Cystic Fibrosis
  • 24.
     This abnormalmucus can clog the airways, leading to severe problems with breathing and bacterial infections in the lungs.  These infections cause chronic coughing, wheezing, and inflammation.  Over time, mucus buildup and infections result in permanent lung damage, including the formation of scar tissue (fibrosis) and cysts in the lungs.
  • 25.
     In peoplewith cystic fibrosis, mucus often damages the pancreas, impairing its ability to produce insulin and digestive enzymes.  Problems with digestion can lead to diarrhea, malnutrition, poor growth, and weight loss.  In adolescence or adulthood, a shortage of insulin can cause a form of diabetes known as cystic fibrosis-related diabetes mellitus (CFRDM).
  • 26.
     Cystic fibrosisused to be considered a fatal disease of childhood.  Adults with cystic fibrosis experience health problems affecting the respiratory, digestive, and reproductive systems.  Most men with cystic fibrosis have congenital bilateral absence of the vas deferens (CBAVD), a condition in which the tubes that carry sperm are blocked by mucus and do not develop properly, causing infertility unless the fertility treatment.  Women with cystic fibrosis may experience complications in pregnancy.
  • 27.
  • 28.
     Mutations inthe transmembrane conductance regulator (CFTR gene) on chromosome 7 cause cystic fibrosis.  The CFTR gene provides instructions for making a channel that transports negatively charged particles called chloride ions into and out of cells.  Chloride is a component of sodium chloride, a common salt found in sweat.  Chloride also has important functions in cells; for example, the flow of chloride ions helps control the movement of water in tissues, which is necessary for the production of thin, freely flowing mucus. Causes
  • 29.
     Mutations inthe CFTR gene disrupt the function of the chloride channels, preventing them from regulating the flow of chloride ions and water across cell membranes.  As a result, cells that line the passageways of the lungs, pancreas, and other organs produce mucus that is unusually thick and sticky.  This mucus clogs the airways and various ducts, causing the characteristic signs and symptoms of cystic fibrosis.
  • 30.
     Other geneticand environmental factors likely influence the severity of the condition.  For example, mutations in genes other than CFTR might help explain why some people with cystic fibrosis are more severely affected than others.  Most of these genetic changes have not been identified, however.
  • 31.
     This conditionis inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations.  The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.  If two carriers have a child, there is a: ◦ 25 percent, or 1 in 4, chance the child will have CF ◦ 50 percent, or 1 in 2, chance the child will be a carrier but will not have CF ◦ 25 percent, or 1 in 4, chance the child will not be a carrier and will not have CF Inheritance Pattern
  • 32.
     Cystic fibrosismay be diagnosed by many different methods, including newborn screening, sweat testing, and genetic testing.  There is currently no cure for CF.  Treatment can manage the symptoms of the disease, however, and improve quality of life.  It is crucial for people with CF to get rid of mucus from their lungs to allow clear breathing and minimize lung infections.  Inhaled medication is effective at reaching the airways and commonly used.  Antibiotics are an important part of regular care.  Gene therapy has been explored as a potential cure for CF. Results from clinical trials have shown limited success as of 2016, and using gene therapy as routine therapy is not suggested. Diagnosis and Management
  • 33.
     Phenylketonuria (PKU)is an inherited disorder with decreased metabolism of the amino acid phenylalanine, resulting in increased levels of this amino acid in the blood.  This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations.  The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition. Phenilketonuria.
  • 34.
     Phenylalanine isa building block of proteins that is obtained through the diet.  When Phe cannot be metabolized by the body, a typical diet that would be healthy for people without PKU causes abnormally high levels of Phe to accumulate in the blood, which is toxic to the brain.  If PKU is not treated, phenylalanine can build up to harmful levels in the body, causing intellectual disability and other serious health problems.  The signs and symptoms of PKU vary from mild to severe.
  • 35.
     The mostsevere form of this disorder is known as classic PKU.  Infants with classic PKU appear normal until they are a few months old.  Without treatment, these children develop permanent intellectual disability.  Seizures, delayed development, behavioral problems, and psychiatric disorders are also common.
  • 36.
     Untreated individualsmay have a musty or mouse- like odor as a side effect of excess phenylalanine in the body.  Children with classic PKU tend to have lighter skin and hair than unaffected family members and are also likely to have skin disorders such as eczema.
  • 37.
     Less severeforms of this condition, sometimes called variant PKU and non-PKU hyperphenylalaninemia, have a smaller risk of brain damage.  People with very mild cases may not require treatment with a low-phenylalanine diet.
  • 38.
     Babies bornto mothers who have PKU and uncontrolled phenylalanine levels (women who no longer follow a low-phenylalanine diet) have a significant risk of intellectual disability because they are exposed to very high levels of phenylalanine before birth.  These infants may also have a low birth weight and grow more slowly than other children.
  • 39.
    Abnormally small head(microcephaly)
  • 40.
     Mutations inthe PAH gene cause phenylketonuria.  The PAH gene provides instructions for making an enzyme called phenylalanine hydroxylase.  This enzyme converts the amino acid phenylalanine to other important amino acid tyrosine.  If gene mutations reduce the activity of phenylalanine hydroxylase, phenylalanine from the diet is not processed effectively.  Phenylalanine accumulates and is converted into phenylpyruvate (also known as phenylketone), which can be detected in the urine.  As a result, this amino acid can build up to toxic levels in the blood and other tissues.  Because nerve cells in the brain are particularly sensitive to phenylalanine levels, excessive amounts of this substance can cause brain damage. Causes
  • 41.
     Classic PKU,the most severe form of the disorder, occurs when phenylalanine hydroxylase activity is severely reduced or absent.  People with untreated classic PKU have levels of phenylalanine high enough to cause severe brain damage and other serious health problems.  Mutations in the PAH gene that allow the enzyme to retain some activity result in milder versions of this condition, such as variant PKU or non-PKU hyperphenylalaninemia.  Changes in other genes may influence the severity of PKU, but little is known about these additional genetic factors.
  • 42.
     PKU iscommonly included in the newborn screening panel of many countries, with varied detection techniques.  Most babies in developed countries are screened for PKU soon after birth.  PKU is not curable.  However, if PKU is diagnosed early enough, an affected newborn can grow up with normal brain development by managing and controlling phenylalanine ("Phe") levels through diet, or a combination of diet and medication. Diagnosis and Management
  • 43.
     People whofollow the prescribed dietary treatment from birth may have no symptoms.  Their PKU would be detectable only by a blood test.  People must adhere to a special diet low in Phe for optimal brain development.  Since Phe is necessary for the synthesis of many proteins, it is required for appropriate growth, but levels must be strictly controlled.
  • 44.
     The dietrequires restricting or eliminating foods high in Phe, such as soybeans, egg whites, shrimp, chicken breast, spirulina, watercress, fish, nuts, crayfish, lobster, tuna, turkey, legumes, and lowfat cottage cheese.  Starchy foods, such as potatoes and corn are generally acceptable in controlled amounts, but the quantity of Phe consumed from these foods must be monitored.
  • 45.
     Sickle celldisease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body.  This condition is inherited in an autosomal recessive pattern.  People with this disorder have atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape.  Signs and symptoms of sickle cell disease usually begin in early childhood.  Characteristic features of this disorder include a low number of red blood cells (anemia), repeated infections, and periodic episodes of pain. Sickle Cell Disease
  • 46.
     The severityof symptoms varies from person to person.  The signs and symptoms of sickle cell disease are caused by the sickling of red blood cells.  When red blood cells sickle, they break down prematurely, which can lead to anemia  Anemia can cause shortness of breath, fatigue, and delayed growth and development in children.  The rapid breakdown of red blood cells may also cause yellowing of the eyes and skin, which are signs of jaundice.
  • 47.
     Painful episodescan occur when sickled red blood cells, which are stiff and inflexible, get stuck in small blood vessels.  These episodes deprive tissues and organs of oxygen- rich blood and can lead to organ damage, especially in the lungs, kidneys, spleen, and brain.  A particularly serious complication of sickle cell disease is high blood pressure in the blood vessels that supply the lungs (pulmonary hypertension).  Pulmonary hypertension occurs in about one-third of adults with sickle cell disease and can lead to heart failure.
  • 48.
     Sickle celldisease affects millions of people worldwide.  It is most common among people whose ancestors come from Africa; Mediterranean countries such as Greece, Turkey, and Italy; the Arabian Peninsula; India; and Spanish-speaking regions in South America, Central America, and parts of the Caribbean.  The disease is estimated to occur in 1 in 500 African Americans and 1 in 1,000 to 1,400 Hispanic Americans. Frequency
  • 50.
     Mutations inthe HBB gene (chromosome 11) cause sickle cell disease.  Hemoglobin consists of four protein subunits, typically, two subunits called alpha-globin and two subunits called beta-globin.  The HBB gene provides instructions for making beta-globin.  Various versions of beta-globin result from different mutations in the HBB gene. Causes
  • 51.
     One particularHBB gene mutation produces an abnormal version of beta-globin known as hemoglobin S (HbS).  Other mutations in the HBB gene lead to additional abnormal versions of beta-globin such as hemoglobin C (HbC) and hemoglobin E (HbE).  HBB gene mutations can also result in an unusually low level of beta-globin.  This abnormality is called beta thalassemia.
  • 52.
     If mutationsthat produce hemoglobin S and beta thalassemia occur together, individuals have hemoglobin S-beta thalassemia (HbSBetaThal) disease.  Abnormal versions of beta-globin can distort red blood cells into a sickle shape.  The sickle-shaped red blood cells die prematurely, which can lead to anemia.  Sometimes the inflexible, sickle-shaped cells get stuck in small blood vessels and can cause serious medical complications.
  • 53.
     In HbS,the complete blood count reveals low hemoglobin levels with a high reticulocyte count.  Abnormal hemoglobin forms can be detected on hemoglobin electrophoresis.  Sickle cell hemoglobin (HgbS) and hemoglobin C with sickling (HgbSC)—the two most common forms—can be identified from there. Diagnosis
  • 54.
     Albinism isa genetic disorder characterized in humans by the complete or partial absence of pigment in the skin, hair and eyes.  Albinism is associated with a number of vision defects.  Lack of skin pigmentation makes for more susceptibility to sunburn and skin cancers.  Albinism results from inheritance of recessive gene alleles and is known to affect all vertebrates, including humans. Albinism
  • 55.
     It isdue to absence or defect of tyrosinase, a copper-containing enzyme involved in the production of melanin.  Albinism is considered to be a hereditary condition characterised by the absence of melanin in particular, in the eyes, skin, hair or feathers.  While an organism with complete absence of melanin is called an albino, an organism with only a diminished amount of melanin is described as albinoid.
  • 56.
     There aretwo principal types of albinism: oculocutaneous, affecting the eyes, skin and hair, and ocular affecting the eyes only.  Because individuals with albinism have skin that entirely lacks the dark pigment melanin, which helps protect the skin from the sun's ultraviolet radiation, their skin can burn more easily from overexposure.  Those with albinism are generally as healthy as the rest of the population, with growth and development occurring as normal, and albinism by itself does not cause mortality  Although the lack of pigment blocking ultraviolet radiation increases the risk of melanomas (skin cancers) and other problems.
  • 58.
     Oculocutaneous albinismis generally the result of the biological inheritance of genetically recessive alleles (genes) passed from both parents of an individual for example OCA1 and OCA2.  Some rare forms are inherited from only one parent.  There are other genetic mutations which are proven to be associated with albinism.  All alterations, however, lead to changes in melanin production in the body  Some of these are associated with increased risk of skin cancer. Causes
  • 59.
     The chanceof offspring with albinism resulting from the pairing of an organism with albinism and one without albinism is low.  Albinism usually occurs with equal frequency in both sexes.  An exception to this is ocular albinism, which it is passed on to offspring through X-linked inheritance.  Thus, ocular albinism occurs more frequently in males as they have a single X and Y chromosome, unlike females, whose genetics are characterized by two X chromosomes.
  • 60.
     People withalbinism will have the following symptoms: ◦ an absence of color in the hair, skin, or eyes ◦ lighter than normal coloring of the hair, skin, or eyes ◦ patches of skin that have an absence of color  Albinism occurs with vision problems, which may include: ◦ strabismus (crossed eyes) ◦ photophobia (sensitivity to light) ◦ nystagmus (involuntary rapid eye movements) ◦ impaired vision or blindness ◦ astigmatism Symptoms
  • 61.
     Since thereis no cure for albinism, it is managed through lifestyle adjustments.  People with albinism need to take care not to get sunburnt and should have regular healthy skin checks by a dermatologist.  Most forms of albinism don’t affect life span. Management
  • 62.